WHO ICTRP trial
Clinical and immunological effects of imiquimod and HPV-vaccination compared to…
EUCTR2008-008251-42-NL · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2008-008251-42-NL |
|---|---|
| Public title | Clinical and immunological effects of imiquimod and HPV-vaccination compared to imiquimod alone in female patients with Usual type VIN - Effects of HPV-vaccination and imiquimod in VIN patients |
| Scientific title | Clinical and immunological effects of imiquimod and HPV-vaccination compared to imiquimod alone in female patients with Usual type VIN - Effects of HPV-vaccination and imiquimod in VIN patients |
| Primary sponsor | Erasmus MC |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Netherlands |
| Conditions | In this trial, the efficacy of Gardasil combined with imiquimod in women with usual type Vulvar Intraepithelial Neoplasia is investigated. MedDRA version: 9.1 Level: LLT Classification code 10047778 Term: Vulvar cancer in situ MedDRA… |
| Interventions | Trade Name: Gardasil Pharmaceutical Form: Suspension for injection Pharmaceutical form of the placebo: Solution for injection Route of administration of the placebo: Intramuscular use Trade Name: Aldara 5% cream Pharmaceutical Form: Cream |
| Registration date | May 1, 2009 |
| Secondary IDs | 26014 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: